World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

Published on Oct 1, 2019in The Lancet Global Health
· DOI :10.1016/S2214-109X(19)30318-3
Stephen Kaptoge57
Estimated H-index: 57
,
Lisa Pennells16
Estimated H-index: 16
+ 98 AuthorsEmanuele Di Angelantonio70
Estimated H-index: 70
Sources
Abstract
Summary Background To help adapt cardiovascular disease risk prediction approaches to low-income and middle-income countries, WHO has convened an effort to develop, evaluate, and illustrate revised risk models. Here, we report the derivation, validation, and illustration of the revised WHO cardiovascular disease risk prediction charts that have been adapted to the circumstances of 21 global regions. Methods In this model revision initiative, we derived 10-year risk prediction models for fatal and non-fatal cardiovascular disease (ie, myocardial infarction and stroke) using individual participant data from the Emerging Risk Factors Collaboration. Models included information on age, smoking status, systolic blood pressure, history of diabetes, and total cholesterol. For derivation, we included participants aged 40–80 years without a known baseline history of cardiovascular disease, who were followed up until the first myocardial infarction, fatal coronary heart disease, or stroke event. We recalibrated models using age-specific and sex-specific incidences and risk factor values available from 21 global regions. For external validation, we analysed individual participant data from studies distinct from those used in model derivation. We illustrated models by analysing data on a further 123 743 individuals from surveys in 79 countries collected with the WHO STEPwise Approach to Surveillance. Findings Our risk model derivation involved 376 177 individuals from 85 cohorts, and 19 333 incident cardiovascular events recorded during 10 years of follow-up. The derived risk prediction models discriminated well in external validation cohorts (19 cohorts, 1 096 061 individuals, 25 950 cardiovascular disease events), with Harrell's C indices ranging from 0·685 (95% CI 0·629–0·741) to 0·833 (0·783–0·882). For a given risk factor profile, we found substantial variation across global regions in the estimated 10-year predicted risk. For example, estimated cardiovascular disease risk for a 60-year-old male smoker without diabetes and with systolic blood pressure of 140 mm Hg and total cholesterol of 5 mmol/L ranged from 11% in Andean Latin America to 30% in central Asia. When applied to data from 79 countries (mostly low-income and middle-income countries), the proportion of individuals aged 40–64 years estimated to be at greater than 20% risk ranged from less than 1% in Uganda to more than 16% in Egypt. Interpretation We have derived, calibrated, and validated new WHO risk prediction models to estimate cardiovascular disease risk in 21 Global Burden of Disease regions. The widespread use of these models could enhance the accuracy, practicability, and sustainability of efforts to reduce the burden of cardiovascular disease worldwide. Funding World Health Organization, British Heart Foundation (BHF), BHF Cambridge Centre for Research Excellence, UK Medical Research Council, and National Institute for Health Research.
Download
📖 Papers frequently viewed together
2012
References52
Newest
#1Lisa Pennells (University of Cambridge)H-Index: 16
#2Stephen Kaptoge (University of Cambridge)H-Index: 57
Last. Johanna M. GeleijnseH-Index: 101
view all 216 authors...
AIMS: There is debate about the optimum algorithm for cardiovascular disease (CVD) risk estimation. We conducted head-to-head comparisons of four algorithms recommended by primary prevention guidelines, before and after 'recalibration', a method that adapts risk algorithms to take account of differences in the risk characteristics of the populations being studied. METHODS AND RESULTS: Using individual-participant data on 360 737 participants without CVD at baseline in 86 prospective studies from...
34 CitationsSource
#1Gregory A. Roth (UW: University of Washington)H-Index: 74
#2Degu Abate (Haramaya University)H-Index: 17
Last. Christopher J L Murray (UW: University of Washington)H-Index: 220
view all 1020 authors...
Summary Background Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD 2017 provides a comprehensive assessment of...
1,673 CitationsSource
#1Spencer L. James (UW: University of Washington)H-Index: 48
#1Gbd DiseaseH-Index: 1
Last. Christopher J L MurrayH-Index: 220
view all 990 authors...
Research reported in this publication was supported by the Bill & Melinda Gates Foundation, the University of Melbourne, Public Health England, the Norwegian Institute of Public Health, St Jude Children’s Research Hospital, the National Institute on Ageing of the National Institutes of Health (award P30AG047845), and the National Institute of Mental Health of the National Institutes of Health (award R01MH110163).
2,402 CitationsSource
#1Romana Pylypchuk (University of Auckland)H-Index: 8
#2Sue Wells (University of Auckland)H-Index: 23
Last. Rod Jackson (University of Auckland)H-Index: 54
view all 15 authors...
Summary Background Most cardiovascular disease risk prediction equations in use today were derived from cohorts established last century and with participants at higher risk but less socioeconomically and ethnically diverse than patients they are now applied to. We recruited a nationally representative cohort in New Zealand to develop equations relevant to patients in contemporary primary care and compared the performance of these new equations to equations that are recommended in the USA. Metho...
71 CitationsSource
#1Martin Bødtker Mortensen (Copenhagen University Hospital)H-Index: 5
#1Martin Bødtker Mortensen (Copenhagen University Hospital)H-Index: 4
Last. Børge G. Nordestgaard (Copenhagen University Hospital)H-Index: 158
view all 2 authors...
Background: Five major organizations recently published guidelines for using statins to prevent atherosclerotic cardiovascular disease (ASCVD): in 2013, the American College of Cardiology/American Heart Association (ACC/AHA); in 2014, the United Kingdom's National Institute for Health and Care Excellence (NICE); and in 2016, the Canadian Cardiovascular Society (CCS), the U.S. Preventive Services Task Force (USPSTF), and the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS...
41 CitationsSource
#1Corina Grey (University of Auckland)H-Index: 13
#2Rod Jackson (University of Auckland)H-Index: 54
Last. Andrew Kerr (University of Auckland)H-Index: 28
view all 8 authors...
Objectives To examine recent trends in first and recurrent ischaemic heart disease (IHD) deaths and hospitalisations. Methods Using anonymous patient-linkage of routinely collected data, all New Zealanders aged 35–84 years who experienced an International Statistical Classification of Diseases and Related Health Problems I(CD)-coded IHD hospitalisation and/or IHD death between 1 January 2005 and 31 December 2015 were identified. A 10-year look-back period was used to differentiate those experien...
17 CitationsSource
#1Leandra Abarca-Gómez (University of Southern Denmark)H-Index: 7
#2Ziad A Abdeen (Imperial College London)H-Index: 2
Last. Majid Ezzati (Imperial College London)H-Index: 138
view all 1024 authors...
BACKGROUND: Underweight, overweight, and obesity in childhood and adolescence are associated with adverse health consequences throughout the life-course. Our aim was to estimate worldwide trends in ...
2,076 CitationsSource
#1Christopher J L Murray (UW: University of Washington)H-Index: 220
#2Alan D. Lopez (University of Melbourne)H-Index: 165
76 CitationsSource
#1Julia Hippisley-Cox (University of Nottingham)H-Index: 70
#2Carol Coupland (University of Nottingham)H-Index: 76
Last. Peter Brindle (University Hospitals Bristol NHS Foundation Trust)H-Index: 22
view all 3 authors...
Objectives To develop and validate updated QRISK3 prediction algorithms to estimate the 10 year risk of cardiovascular disease in women and men accounting for potential new risk factors. Design Prospective open cohort study. Setting General practices in England providing data for the QResearch database. Participants 1309 QResearch general practices in England: 981 practices were used to develop the scores and a separate set of 328 practices were used to validate the scores. 7.89 million patients...
357 CitationsSource
#1Kunal N. Karmali (NU: Northwestern University)H-Index: 15
#2Stephen D. Persell (NU: Northwestern University)H-Index: 31
Last. Mark D. Huffman (NU: Northwestern University)H-Index: 44
view all 6 authors...
Background The current paradigm for cardiovascular disease (CVD) emphasises absolute risk assessment to guide treatment decisions in primary prevention. Although the derivation and validation of multivariable risk assessment tools, or CVD risk scores, have attracted considerable attention, their effect on clinical outcomes is uncertain. Objectives To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes, risk factor levels, prev...
42 CitationsSource
Cited By101
Newest
#1Zhouguang Wang (WMU: Wenzhou Medical College)H-Index: 2
#1Zhouguang Wang (WMU: Wenzhou Medical College)H-Index: 1
Last. Xiaokun Li (WMU: Wenzhou Medical College)H-Index: 5
view all 8 authors...
Abstract Heart disease is still the leading killer all around the world, and its incidence is expected to increase over the next decade. Previous reports have already shown the role of fibroblast growth factor10 (FGF10) in alleviating heart diseases. However, FGF10 has not been used to treat heart diseases because the free protein has short half-life and low bioactivity. Here, an injectable coacervate was designed to protect growth factor from degradation during delivery and the effects of the F...
Source
#2Johanna M. Geleijnse (WUR: Wageningen University and Research Centre)H-Index: 101
Last. Erik J. Giltay (LEI: Leiden University)H-Index: 70
view all 5 authors...
Abstract Background Mental well-being, characterized by low depressive symptoms and high dispositional optimism, is a protective factor against (cardiovascular) mortality in the general population. We aimed to assess whether such a relationship is also present in patients who have a history of MI, and whether it is independent of classic CVD risk factors. Methods A secondary analysis of the Alpha Omega Trial cohort study was carried out, including 3566 patients with MI in their medical history a...
Source
#1Mph Michael J. Blaha Md (Johns Hopkins University)H-Index: 1
#2Andrew P. DeFilippis (VUMC: Vanderbilt University Medical Center)H-Index: 34
The MESA (Multi-Ethnic Study of Atherosclerosis) is a National Heart, Lung, and Blood Institute-sponsored prospective study aimed at studying the prevalence, progression, determinants, and prognostic significance of subclinical cardiovascular disease in a sex-balanced, multiethnic, community-dwelling U.S. cohort. MESA helped usher in an era of noninvasive evaluation of subclinical atherosclerosis presence, burden, and progression for the evaluation of atherosclerotic cardiovascular disease risk,...
Source
#1Laurie Abbott (FSU: Florida State University)H-Index: 5
#2Lucinda J. Graven (FSU: Florida State University)H-Index: 9
Last. Krystal J. Williams (FAMU: Florida A&M University)H-Index: 1
view all 0 authors...
Cardiovascular disease is a global public health problem and leading cause of death. Stress is a modifiable cardiovascular disease risk factor. The objectives of this study were to examine whether stress was a predictor of resilience among rural younger women and to explore whether social support mediated the relationship between acute stress and resilience and between chronic stress and resilience. The study had a cross-sectional, descriptive design. A total of 354 women were randomly recruited...
Source
Phospholipid complexation, despite being a successful, versatile, and burgeoning strategy, stickiness of phospholipids leads to suboptimal dissolution rate of drugs. This work was undertaken to fabricate simvastatin-phospholipid complex (SIM-PLC)–loaded matrix dispersion (SIM-PLC-MD) using Soluplus® as carrier material, to augment dispersibility and dissolution of SIM-PLC without altering complexation between simvastatin (SIM) and phospholipid. SIM-PLC and SIM-PLC-MD were prepared using solvent ...
Source
Abstract null null Clinical estimation of the combined effect of several risk factors is unreliable and this resulted in the development of a number of risk estimation systems to guide clinical practice. Here, after defining general principles of risk estimation, the authors describe the evolution of the European Society of Cardiology’s (ESC) Systematic COronary Risk Evaluation (SCORE) risk estimation system and some learnings from the data. They move on to describe the establishment of the ESC’...
Source
#1Jinho Kim (KU: Korea University)
#1Jinho Kim (KU: Korea University)H-Index: 6
OBJECTIVE Personality traits and health are strongly correlated, but unobserved family-level characteristics may confound this relationship. This study investigates whether associations between personality traits and physical health are spurious owing to unobserved family background. DESIGN Participants were from the National Longitudinal Study of Adolescent to Adult Health. This study employed sibling fixed-effect approach to account for unobserved family characteristics. MAIN OUTCOME MEASURES ...
Source
Source
#3Steven H J HagemanH-Index: 3
#4Lisa PennellsH-Index: 16
Last. Frank KeeH-Index: 76
view all 0 authors...
2 CitationsSource
#3Tamar I. de VriesH-Index: 4
Last. Zhe XuH-Index: 2
view all 0 authors...
2 CitationsSource